Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sanofi India

Sanofi India

BSE: 500674|NSE: SANOFI|ISIN: INE058A01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 11, 11:00
6980.00
43.2 (0.62%)
VOLUME 13
LIVE
NSE
Dec 11, 11:10
6975.00
26.7 (0.38%)
VOLUME 1,469
News on Sanofi India
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Themis, Aventis in tech-transfer deal

8.30 am | 28 Jul 2007

Themis Laboratories Pvt Ltd has signed a technology transfer agreement with Aventis Pharma Ltd for fixed-dose combinations using two of its best selli...

Nicholas can touch Rs 325 

4.37 pm | 14 Jun 2007

Technical Analyst, Rajat K Bose is of the view that Nicholas Piramal can touch Rs 325. ...

Aventis Pharma Ltd announces its sales & profit for Q1 2007

11.30 am | 17 Apr 2007

Aventis Pharma Limited announces its Sales and Profit for Q1 2007 ...

Aventis Pharma Q1 net profit at Rs 43.3cr

9.30 am | 17 Apr 2007

Aventis Pharma has announced its first quarter results. The company posted net profit of Rs 43.3 crore as against Rs 36.9 crore in corresponding quart...

Motilal Oswal maintains buy rating on Aventis Pharma

3.47 pm | 09 Apr 2007

Motilal Oswal has come out with a report on Aventis Pharma. It has maintained buy rating on the stock....

Aventis Q1 PAT seen up 26.8% to Rs 468mn: Motilal Oswal

3.40 pm | 09 Apr 2007

Motilal Oswal has come with pre earning report on pharmaceutical companies for quarter ended March FY07. It expects Aventis Pharmas sales to grow at ...

Buy Aventis Pharma: ICICI Securities

2.00 pm | 29 Mar 2007

Broking house, ICICI Securities is bullish on Aventis Pharma and has maintained buy rating on the stock....

Buy Aventis Pharma; target of Rs 1520: Karvy

11.59 am | 29 Mar 2007

Broking house, Karvy Stock Broking is bullish on Aventis Pharma and has recommended buy rating on the stock with a target of Rs 1520....

Aventis Q4 net profit at Rs 34.7cr

9.30 am | 28 Mar 2007

Aventis Pharma has come out with fourth quarter results. The company reported net profit of Rs 34.7 crore versus Rs 37.6 crore in the corresponding qu...

Churn in top echelons of pharma sector

8.45 am | 13 Mar 2007

Last week Aventis Pharma Ltd informed the BSE that Dr S. Bhattacharya had resigned from the company as Wholetime Director and Alternate Director. ...

Buy Aventis Pharma; target of Rs 1643: Kotak

3.24 pm | 03 Jan 2007

Broking house, Kotak Securities is bullish on Aventis Pharma and has recommended buy rating on the stock with a target price of Rs 1643....

Aventis Pharma Q3 net seen at Rs 43.3cr: ICICI Sec

2.48 pm | 03 Jan 2007

Broking house, ICICI Securities estimates that Aventis Pharmas net profit is expected to be at Rs 43.3 crore in Q4CY06 versus Rs 42 crore in the same...

1
Quick Links for Sanofi India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.